about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Con...
Read More
21.57
0.06
(0.28%)
93,503
XNAS Volume
XNAS 16 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Neurogene Inc is on 24 Mar 2026 for the purpose of Neurogene Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..